Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography

In 32 patients with gliomas, one- and two-dimensional proton magnetic resonance spectroscopy (1H-MRS) has been conducted, the latter allowing reconstruction of spectroscopic data into a spectroscopic image (MRSI), showing the distribution of the various metabolite concentrations over the cross-sectional plane. For lack of absolute concentrations, the measured concentrations of phosphocholine (CHOL),N-acetyl-L-aspartate (NAA), and lactate (LAC) were conventionally expressed in ratios relative to that of creatine (CREAT). Compared to normal brain tissue, an increased CHOL/CREAT ratio was found in all groups of tumours, in glioblastomas, high-, middle- and low-grade astrocytomas both at the margin and the core of the tumours, but in oligodendrogliomas only at the margin. This is consistent with an increased phosphocholine turnover in relation to membrane biosynthesis by the proliferating cells. The NAA/CREAT ratio was decreased in all groups of tumours, both in the centre and at the margin, reflecting replacement of functioning neurons by neoplastic cells. The LAC/ CREAT ratio was elevated in the core of malignant gliomas, which may be the result of a prevailing glycolysis, characteristic of tumours, possibly in conjunction with hypoxia/ischaemia. In the perifocal oedema, there was neither elevation of the CHOL/CREAT ratio nor decrease of the NAA/CREAT ratio; an increased LAC/CREAT ratio therefore rather reflected ischaemia/hypoxia probably due to locally elevated pressure and compromised regional perfusion. In the normal brain, the metabolite ratios of grey matter did not differ from those of white matter. The frontal lobe and basal ganglia showed lower NAA/CREAT ratios than the other cerebral areas. In 7 patients positron emission tomography was also performed with [18F]fluoro-2-deoxy-D-glucose (18FDG) or L-[1-11C]-tyrosine (11C-TYR); the latter demonstrated a pattern of11C-TYR uptake similar to that of CHOL elevation in the MRSI.

[1]  A. Ruifrok,et al.  Non‐invasive In Vivo localized 1H spectroscopy of human astrocytoma implanted in rat brain: Regional differences followed in time , 1991, NMR in biomedicine.

[2]  P A Bottomley,et al.  Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? , 1989, Radiology.

[3]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[4]  W. Vaalburg,et al.  Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[6]  J. Olesen,et al.  Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis , 1991, Magnetic resonance in medicine.

[7]  J. Pruim,et al.  Contribution of Magnetic Resonance Spectroscopic Imaging and L-[1-11C]Tyrosine Positron Emission Tomography to Localization of Cerebral Gliomas for Biopsy , 1994 .

[8]  F. Yatsu,et al.  ACETATE METABOLISM IN THE NERVOUS SYSTEM. N‐ACETYL‐l‐ASPARTIC ACID AND THE BIOSYNTHESIS OF BRAIN LIPIDS * , 1966, Journal of neurochemistry.

[9]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[10]  R. Brooks,et al.  Correlation of experimental and clinical studies of metabolism by PET scanning. , 1984, Progress in experimental tumor research.

[11]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  J. Frahm,et al.  Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.

[13]  J. Pruim,et al.  Contribution of magnetic resonance spectroscopic imaging and L-[1-11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. , 1994, Neurosurgery.

[14]  G B Matson,et al.  Human brain infarction: proton MR spectroscopy. , 1992, Radiology.

[15]  David Hilton-Jones,et al.  BIOCHEMICAL INVESTIGATION OF HUMAN TUMOURS IN VIVO WITH PHOSPHORUS-31 MAGNETIC RESONANCE SPECTROSCOPY , 1986, The Lancet.

[16]  J. Cooper,et al.  METABOLISM OF THE ASPARTYL MOIETY OF N‐ACETYL‐l‐ASPARTIC ACID IN THE RAT BRAIN , 1972, Journal of neurochemistry.

[17]  W. Vaalburg,et al.  Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET) , 2004, European Journal of Nuclear Medicine.

[18]  K. Go Cerebral pathophysiology : an integral approach with some emphasis on clinical implications , 1991 .

[19]  G Di Chiro,et al.  Prediction of survival in glioma patients by means of positron emission tomography. , 1985, Journal of neurosurgery.

[20]  N. M. Alpert,et al.  Measurement of Brain pH Using 11CO2 and Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Pruim,et al.  Cystic lesions of the brain. A classification based on pathogenesis, with consideration of histological and radiological features. , 1993, European journal of radiology.

[22]  P R Luyten,et al.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.

[23]  K. Ishiwata,et al.  In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[24]  O. Warburg On the origin of cancer cells. , 1956, Science.

[25]  J A Frank,et al.  Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.

[26]  D. Thomas,et al.  Studies on Regional Cerebral pH in Patients with Cerebral Tumours Using Continuous Inhalation of 11CO2 and Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  P. W. Hochachka,et al.  Protons and anaerobiosis. , 1983, Science.

[28]  M. Heesters,et al.  Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy , 1993, Journal of Neuro-Oncology.

[29]  M. Itoh,et al.  Tumor uptake study of 18F-labeled N-acetylneuraminic acids. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[30]  B. Tunggal,et al.  In vivo 13c nuclear magnetic resonance investigations of choline metabolism in rabbit brain , 1990, Magnetic resonance in medicine.

[31]  Barry H. Smith,et al.  Regulation of hexokinase in cultured gliomas. , 1985, Neurosurgery.

[32]  T. Yoshimoto,et al.  Intratumoral oxygen pressure in malignant brain tumor. , 1991, Journal of neurosurgery.

[33]  G. Cruickshank,et al.  Peri-tumoural hypoxia in human brain: peroperative measurement of the tissue oxygen tension around malignant brain tumours. , 1994, Acta neurochirurgica. Supplementum.

[34]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[35]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.